Pervasis in Advanced Talks With Potential Partners for Blood Vessel Product

Pervasis Therapeutics, a Cambridge, MA-based developer of cellular therapies, has had the green light from the FDA to start a pivotal clinical trial of its lead candidate for improving blood vessel access in hemodialysis patients for about a year.
Xconomy